[{"HigherRiskReferralReasonId":1,"HigherRiskReferralReasonCode":"AT_HETEROZYGOTES","HigherRiskReferralReasonCodeDescription":"A-T heterozygotes"},{"HigherRiskReferralReasonId":2,"HigherRiskReferralReasonCode":"AT_HOMOZYGOTES","HigherRiskReferralReasonCodeDescription":"A-T homozygotes"},{"HigherRiskReferralReasonId":3,"HigherRiskReferralReasonCode":"BRCA_RISK","HigherRiskReferralReasonCodeDescription":"BRCA1/BRCA2/PALB2 (8% 10-year risk)"},{"HigherRiskReferralReasonId":4,"HigherRiskReferralReasonCode":"BRCA_TESTED","HigherRiskReferralReasonCodeDescription":"BRCA1/BRCA2/PALB2 Tested"},{"HigherRiskReferralReasonId":5,"HigherRiskReferralReasonCode":"HR_GENE_UNTESTED","HigherRiskReferralReasonCodeDescription":"HR Gene untested"},{"HigherRiskReferralReasonId":6,"HigherRiskReferralReasonCode":"OTHER_GENE_MUTATIONS","HigherRiskReferralReasonCodeDescription":"Other gene mutations"},{"HigherRiskReferralReasonId":7,"HigherRiskReferralReasonCode":"RADIOTHERAPY_BELOW_30","HigherRiskReferralReasonCodeDescription":"Radiotherapy below aged 30"},{"HigherRiskReferralReasonId":8,"HigherRiskReferralReasonCode":"RADIOTHERAPY_LOWER","HigherRiskReferralReasonCodeDescription":"Radiotherapy to breast tissue aged 10-19"},{"HigherRiskReferralReasonId":9,"HigherRiskReferralReasonCode":"RADIOTHERAPY_UPPER","HigherRiskReferralReasonCodeDescription":"Radiotherapy to breast tissue aged 20-35"},{"HigherRiskReferralReasonId":10,"HigherRiskReferralReasonCode":"RISK_EQUIVALENT","HigherRiskReferralReasonCodeDescription":"Risk equivalent, not tested"},{"HigherRiskReferralReasonId":11,"HigherRiskReferralReasonCode":"TP53","HigherRiskReferralReasonCodeDescription":"TP53 (Li-Fraumeni) syndrome"}]